Fly Intel: Top five analyst initiations » 10:0007/2307/23/21
THC, PLUG, OGN, MP, PLL
Catch up on today's…
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Tenet Healthcare (THC) reinstated with a Buy at Citi. 2. Plug Power (PLUG) initiated with a Buy at Citi. 3. Organon (OGN) initiated with a Buy, $35 target at Citi. 4. MP Materials (MP) initiated with a Buy at DA Davidson. 5. Piedmont Lithium (PLL) initiated with a Buy at DA Davidson. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
Plug Power initiated with a Buy at Citi » 08:1807/2307/23/21
Citi analyst P.J. Juvekar…
Story temporarily locked.
Roth Capital sustainability analyst holds an analyst/industry conference call » 10:2507/2207/22/21
ENPH, GNRC, SEDG, NOVA, RUN, SPWR, SUNW
Managing Director &…
Managing Director & Sustainability Analyst Shen, along with the Founder of Ohm Analytics, Chris Collins, discuss the forecasts for 2Q and 3Q U.S. residential solar installations, including a preview of forecasts by inverter type on an Analyst/Industry conference call to be held on July 22 at 11 am. Webcast Link
Largest borrow rate increases among liquid names » 08:4507/2207/22/21
GOEV, LIT, LABD, SOLO, OWL, GT, XELA, CL, VLDR, FTCV
Latest data shows the…
Latest data shows the largest indicative borrow rate increases among liquid option names include: Canoo (GOEV) 22.79% +3.48, Global X Lithium (LIT) 1.21% +0.46, Direxion S&P Biotech Bear 3X (LABD) 12.08% +0.42, Electrameccanica Vehicles Corp (SOLO) 5.36% +0.35, Blue Owl Capital (OWL) 89.24% +0.34, Goodyear Tire (GT) 0.59% +0.34, (XELA) 19.74% +0.29, Colgate Palmolive (CL) 0.67% +0.28, Velodyne Lidar (VLDR) 8.25% +0.16, and FinTech Acquisition Corp V (FTCV) 20.91% +0.14.
Tortoise Acquisition Corp. II partners with StreetLight for EV charging solution » 08:4007/2207/22/21
Tortoise Acquisition Corp. II's combination agreement partner Volta Industries, a provider of commerce-centric electric vehicle - EV - charging networks, announced a strategic partnership with StreetLight Data, a provider of big data analytics for mobility, to use their combined analytics for the intelligent deployment of EV infrastructure. The partnership is intended to spur public sector agencies, utilities, transportation planners and engineering firms, among others, to accelerate EV adoption through Volta's PredictEV SaaS solution and StreetLight's mobility data. Volta Charging and Tortoise Acquisition Corp. II entered into a business combination agreement in February subject to customary closing conditions, under which the combined entity will be named Volta and remain on the NYSE under the new ticker symbol "VLTA". PredictEV is a machine-learning tool that helps utilities, municipalities and companies predict electric vehicle adoption and demand for EV charging. Through this partnership, Volta Charging will provide its PredictEV tool to StreetLight customers. StreetLight will also provide Volta Charging with opportunities to expand its market footprint across the U.S. through increased collaboration with transportation planners, engineering firms and public agencies focused on transportation electrification.
Catalyst Biosciences announce first patient screened for CFI deficiency in study » 08:2107/2207/22/21
Catalyst Biosciences announced the screening of the first patient in its CFI-deficiency study in the CB 4332 program, its wholly-owned, first-in-class, enhanced Complement Factor I, intended for prophylactic subcutaneous administration in individuals with CFI deficiency. "The findings from the CFI deficiency screening and natural history of disease studies will be instrumental in identifying patients for the Phase 1/2 trial of CB 4332, planned for mid-year 2022," said Nassim Usman, Ph.D., president and chief executive officer of Catalyst. "Following the disease manifestations and biomarkers of this complement disorder will be important in unlocking the full therapeutic potential of CB 4332." The ConFIrm screening study will measure CFI levels and activity in patients who have diseases related to a CFI deficiency and who may potentially benefit from CB 4332 treatment. The ConFIdence natural history of disease study will follow these CFI-deficient subjects, who often present with repetitive bacterial infections, immune-related diseases, and/or glomerulopathies, for clinical biomarkers and safety of current treatments. The findings from these studies will identify opportunities to potentially develop CB 4332 for treatment in multiple indications.
NV5 Global selected by Hong Kong Hospital Authority for $5M engineering contract » 08:1407/2207/22/21
NV5 Global announced that…
NV5 Global announced that the Hospital Authority of the Hong Kong Special Administrative Region has selected NV5 for a $5M contract to provide Building Services Term Consultancy Engineering Services. Under this contract, NV5 will provide mechanical, electrical, plumbing, and fire protection engineering services for all six of the hospitals and the general outpatient centers located in the Hong Kong Island West Region. This is the second consecutive term NV5 has been awarded the contract, which will run through 2026. "NV5's capabilities in MEP-FP and technology design, commissioning, and subscription-based energy efficiency services provide a unique value for our clients in the healthcare, education, data center, hospitality, residential, and commercial sectors," said Dickerson Wright, PE, Chairman and CEO of NV5. "We continue to see strong demand for these services, driving the performance of our international business and the pipeline of opportunities for our ongoing growth in the Asia and Middle East markets."
Plug Power hires David Mindnich as executive vice president of manufacturing » 07:4607/2207/22/21
Plug Power (PLUG) has…
Plug Power (PLUG) has announced that David Mindnich will join the company as executive vice president of global manufacturing. In this role, Mindnich, who will report directly to CEO Andy Marsh, will lead the modernization of Plug Power's manufacturing operations by creating process efficiencies and transforming its operations. He will be responsible for optimizing the performance of Plug Power's global manufacturing facilities by tapping his experience with high-volume global manufacturing, process improvement and automation. Prior to joining Plug Power, Mindnich spent the last five years in several different roles at Tesla's (TSLA) Gigafactory in Nevada. Most recently, Mindnich served as senior director of operations where he oversaw a team of 5,000 employees at the world's largest battery and powertrain manufacturing facility.
Roth Capital sustainability analyst holds an analyst/industry conference call » 04:5507/2207/22/21
ENPH, GNRC, SEDG, NOVA, RUN, SPWR, SUNW
Managing Director &…
Managing Director & Sustainability Analyst Shen, along with the Founder of Ohm Analytics, Chris Collins, discuss the forecasts for 2Q and 3Q U.S. residential solar installations, including a preview of forecasts by inverter type on an Analyst/Industry conference call to be held on July 22 at 11 am.
CareCloud announces ongoing support of Medical Group Management Association » 09:2307/2107/21/21
CareCloud announced its…
CareCloud announced its corporate membership and annual conference sponsorship of the Medical Group Management Association. As both member and marquee sponsor, CareCloud is continuing its commitment to MGMA, which is focused on providing support solutions, services and education to today's multifaceted care providers, leaders and executives. As a Corporate Member, CareCloud will spend the next twelve months collaborating with MGMA in the ideation and delivery of thought-provoking resources for practice leaders, including but not limited to, podcasts, webinars, and other industry-focused assets to promote clinical and operational excellence.